ArticlemedRxiv : the preprint server for health sciences2025
Ex vivo hypothermic oxygenated perfusion allows extended heart preservation in a donation-after-circulatory-death porcine model.
Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
15 authors.
Funding
Abstract
Objectives: Donation after circulatory death (DCD) expands the donor heart pool but is limited by warm ischemia and short preservation times. Hypothermic oxygenated perfusion (HOPE) extends storage beyond the 4-6-hour limit of static cold storage (SCS), yet cellular and molecular responses remain undefined. We evaluate cardiomyocyte integrity and functional recovery of DCD porcine hearts after in situ reanimation with normothermic regional perfusion (NRP) and preservation by SCS (2h) or HOPE (24h) and assess the impact of NRP under DCD conditions. Methods: Nine Yorkshire pigs underwent DCD cardiectomy. Six animals experienced 15 min warm ischemia followed by 60 min NRP. Three hearts were preserved for 2h with SCS and three for 24h with HOPE. A second DCD group (n=3) underwent direct procurement without NRP and 2h of HOPE preservation. All hearts were reanimated by normothermic machine perfusion to assess rhythm and contractility. Cardiomyocyte viability, transcriptomics, and metabolomics were analyzed. Results: After DCD+NRP, 2h SCS preserved intact cardiomyocyte viability. HOPE maintained measurable, though reduced, viability at 24h, while 24h SCS failed even under donation after brain death (DBD) conditions. Transcriptomic and metabolomic analyses showed marginal differences between 2h SCS and 24h HOPE. All 24h HOPE hearts regained sinus rhythm but showed reduced contractility vs 2h SCS. Without NRP, 2h HOPE hearts showed the lowest viability and contractility. Conclusions: HOPE supports extended preservation of DCD hearts, but viability and function decline by 24h. NRP is essential for functional recovery of hearts preserved at hypothermic temperatures in a porcine preclinical DCD model.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.